• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于正念减压疗法对间质性膀胱炎患者尿液微生物群的影响。

The effect of mindfulness-based stress reduction on the urinary microbiome in interstitial cystitis.

作者信息

Shatkin-Margolis Abigail, White James, Jedlicka Anne E, Tam Tiffanie, Hill Austin, Yeung Jennifer, Crisp Catrina C, Pauls Rachel N

机构信息

Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics & Gynecology, Good Samaritan Hospital TriHealth, Cincinnati, OH, USA.

Kaiser Permanente-Dublin Medical Offices & Cancer Center, 3100 Dublin Blvd, Dublin, CA, 94568, USA.

出版信息

Int Urogynecol J. 2022 Mar;33(3):665-671. doi: 10.1007/s00192-021-04812-z. Epub 2021 May 15.

DOI:10.1007/s00192-021-04812-z
PMID:33991218
Abstract

INTRODUCTION AND HYPOTHESIS

The objective was to investigate the impact of mindfulness-based stress reduction therapy on the urinary microbiome of patients with interstitial cystitis/bladder pain syndrome.

METHODS

In this Institutional Review Board-approved prospective cohort study, patients with interstitial cystitis/bladder pain syndrome were recruited to attend an 8-week mindfulness-based stress reduction course involving yoga and meditation. Eligible participants were English-speaking women aged 18 or older with interstitial cystitis/bladder pain syndrome. All participants had a negative urinalysis within 2 months of enrollment and were currently undergoing first- or second-line treatment at the time of recruitment. The mindfulness-based stress reduction course met weekly for 1 h. A straight-catheter urine sample was obtained prior to and following the mindfulness-based stress reduction series. DNA from urine samples underwent bacterial 16S ribosomal gene sequencing at Johns Hopkins University Laboratories followed by taxonomic abundance and diversity analysis by Resphera Biosciences Laboratory. Participants completed validated symptom questionnaires pre- and post-intervention.

RESULTS

A total of 12 participants completed the 8-week course and were included in the analysis. The average age was 59 and the majority identified as white. Patient symptoms, measured by the Urogenital Distress Inventory Short Form and Interstitial Cystitis Symptom and Pain Indices, improved significantly (all p < 0.05). Overall composition of the urinary microbiome changed significantly (p < 0.01) and demonstrated an increase in diversity following the intervention.

CONCLUSIONS

Mindfulness-based stress reduction therapy improves patient symptoms and was associated with significant changes in the urinary microbiome in patients with interstitial cystitis/bladder pain syndrome.

摘要

引言与假设

本研究旨在探讨基于正念减压疗法对间质性膀胱炎/膀胱疼痛综合征患者尿液微生物群的影响。

方法

在这项经机构审查委员会批准的前瞻性队列研究中,招募了间质性膀胱炎/膀胱疼痛综合征患者参加为期8周的包含瑜伽和冥想的正念减压课程。符合条件的参与者为年龄在18岁及以上、患有间质性膀胱炎/膀胱疼痛综合征且说英语的女性。所有参与者在入组后2个月内尿液分析结果均为阴性,且在招募时正在接受一线或二线治疗。基于正念减压的课程每周进行1小时。在正念减压课程系列前后分别采集一次导尿尿液样本。尿液样本的DNA在约翰·霍普金斯大学实验室进行细菌16S核糖体基因测序,随后由Resphera生物科学实验室进行分类丰度和多样性分析。参与者在干预前后完成经过验证的症状问卷。

结果

共有12名参与者完成了为期8周的课程并纳入分析。平均年龄为59岁,大多数为白人。通过泌尿生殖系统困扰量表简表以及间质性膀胱炎症状和疼痛指数测量的患者症状有显著改善(所有p<0.05)。尿液微生物群的总体组成发生了显著变化(p<0.01),并且在干预后多样性增加。

结论

基于正念减压疗法可改善间质性膀胱炎/膀胱疼痛综合征患者的症状,并与尿液微生物群的显著变化相关。

相似文献

1
The effect of mindfulness-based stress reduction on the urinary microbiome in interstitial cystitis.基于正念减压疗法对间质性膀胱炎患者尿液微生物群的影响。
Int Urogynecol J. 2022 Mar;33(3):665-671. doi: 10.1007/s00192-021-04812-z. Epub 2021 May 15.
2
Mindfulness-based stress reduction as a novel treatment for interstitial cystitis/bladder pain syndrome: a randomized controlled trial.基于正念减压疗法作为间质性膀胱炎/膀胱疼痛综合征的一种新治疗方法:一项随机对照试验。
Int Urogynecol J. 2016 Nov;27(11):1705-1711. doi: 10.1007/s00192-016-3022-8. Epub 2016 Apr 26.
3
Urinary Microbiome and Cytokine Levels in Women With Interstitial Cystitis.间质性膀胱炎女性的尿液微生物群和细胞因子水平
Obstet Gynecol. 2017 Mar;129(3):500-506. doi: 10.1097/AOG.0000000000001892.
4
Interstitial cystitis/bladder pain syndrome and recurrent urinary tract infection and the potential role of the urinary microbiome.间质性膀胱炎/膀胱疼痛综合征和复发性尿路感染以及尿微生物组的潜在作用。
Post Reprod Health. 2020 Jun;26(2):87-90. doi: 10.1177/2053369120936426.
5
Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States.美国成年女性膀胱疼痛综合征/间质性膀胱炎症状的流行情况。
J Urol. 2011 Aug;186(2):540-4. doi: 10.1016/j.juro.2011.03.132. Epub 2011 Jun 16.
6
The overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: a questionnaire based analysis.间质性膀胱炎/膀胱疼痛综合征与膀胱过度活动症自我报告症状的重叠与区别:一项基于问卷的分析
J Urol. 2014 Dec;192(6):1679-85. doi: 10.1016/j.juro.2014.05.102. Epub 2014 Jun 5.
7
A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.一项评估新型口服 SHIP1 激活剂 AQX-1125 治疗中重度间质性膀胱炎/膀胱疼痛综合征受试者疗效和安全性的 II 期研究。
J Urol. 2016 Sep;196(3):747-54. doi: 10.1016/j.juro.2016.03.003. Epub 2016 Mar 9.
8
Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis/bladder pain syndrome.与间质性膀胱炎/膀胱疼痛综合征女性疼痛模式表型相关的临床和心理参数。
J Urol. 2015 Jan;193(1):138-44. doi: 10.1016/j.juro.2014.07.108. Epub 2014 Aug 1.
9
Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management.女性间质性膀胱炎/膀胱疼痛综合征的临床表型分析:分类的关键,潜在改善管理。
J Urol. 2009 Jul;182(1):155-60. doi: 10.1016/j.juro.2009.02.122. Epub 2009 May 17.
10
The bacterial microbiota of Hunner lesion interstitial cystitis/bladder pain syndrome.亨纳病变间质性膀胱炎/膀胱疼痛综合征的细菌微生物组。
BJU Int. 2022 Jan;129(1):104-112. doi: 10.1111/bju.15519. Epub 2021 Jul 5.

引用本文的文献

1
Systemic ozone therapy improves the quality of life in patients with bladder pain syndrome.全身臭氧疗法可改善膀胱疼痛综合征患者的生活质量。
Bladder (San Franc). 2025 Aug 1;12(3):e21200054. doi: 10.14440/bladder.2025.0002. eCollection 2025.
2
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS.间质性膀胱炎/膀胱疼痛综合征的病理生理学及潜在多模式治疗策略
Nat Rev Urol. 2025 May 15. doi: 10.1038/s41585-025-01044-4.
3
Urinary Microbiome in Bladder Diseases-Review.膀胱疾病中的泌尿微生物群——综述
Biomedicines. 2023 Oct 17;11(10):2816. doi: 10.3390/biomedicines11102816.
4
Treatment Outcomes of Intravesical Botulinum Toxin A Injections on Patients with Interstitial Cystitis/Bladder Pain Syndrome.膀胱内注射肉毒毒素 A 治疗间质性膀胱炎/膀胱疼痛综合征患者的疗效。
Toxins (Basel). 2022 Dec 11;14(12):871. doi: 10.3390/toxins14120871.
5
Multimodal Treatment with Cognitive Behavioral Therapeutic Intervention Plus Bladder Treatment Is More Effective than Monotherapy for Patients with Interstitial Cystitis/Bladder Pain Syndrome-A Randomized Clinical Trial.认知行为治疗干预加膀胱治疗的多模式治疗对间质性膀胱炎/膀胱疼痛综合征患者比单一疗法更有效——一项随机临床试验
J Clin Med. 2022 Oct 21;11(20):6221. doi: 10.3390/jcm11206221.